NASDAQ:MLAB - Mesa Laboratories Stock Price, Forecast & News

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

Mesa Laboratories declared a quarterly dividend on Thursday, January 9th. Shareholders of record on Friday, February 28th will be paid a dividend of $0.16 per share on Monday, March 16th. This represents a $0.64 dividend on an annualized basis and a yield of 0.24%. The ex-dividend date of this dividend is Thursday, February 27th. View Mesa Laboratories' Dividend History.

Mesa Laboratories, Inc. (NASDAQ:MLAB) issued its quarterly earnings results on Wednesday, November, 6th. The medical instruments supplier reported $1.45 earnings per share for the quarter, missing the Zacks' consensus estimate of $1.50 by $0.05. The medical instruments supplier had revenue of $25.54 million for the quarter, compared to analysts' expectations of $26 million. Mesa Laboratories had a net margin of 9.45% and a return on equity of 17.61%. View Mesa Laboratories' Earnings History.

Mesa Laboratories is scheduled to release their next quarterly earnings announcement on Monday, February 3rd 2020. View Earnings Estimates for Mesa Laboratories.

3 Wall Street analysts have issued 1-year target prices for Mesa Laboratories' stock. Their forecasts range from $250.00 to $275.00. On average, they expect Mesa Laboratories' stock price to reach $262.50 in the next twelve months. This suggests that the stock has a possible downside of 1.1%. View Analyst Price Targets for Mesa Laboratories.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mesa Laboratories in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Mesa Laboratories.

News stories about MLAB stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Mesa Laboratories earned a media sentiment score of -1.5 on InfoTrie's scale. They also gave news articles about the medical instruments supplier a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Mesa Laboratories.

Some companies that are related to Mesa Laboratories include Cognex (CGNX), FLIR Systems (FLIR), National Instruments (NATI), Coherent (COHR), Itron (ITRI), Badger Meter (BMI), OSI Systems (OSIS), FARO Technologies (FARO), MTS Systems (MTSC), Vishay Precision Group (VPG) and Daktronics (DAKT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Intel (INTC), Micron Technology (MU), Verizon Communications (VZ), Alibaba Group (BABA), Coupa Software (COUP), PepsiCo (PEP), Becton Dickinson and (BDX), Walt Disney (DIS) and Mcdonald's (MCD).

Mesa Laboratories' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include 6 Meridian (0.09%), State of Alaska Department of Revenue (0.07%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own Mesa Laboratories stock include David M Kelly, Evan Guillemin, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks, Robert V Dwyer and Seg Ventures, Llc. View Institutional Ownership Trends for Mesa Laboratories.

MLAB stock was sold by a variety of institutional investors in the last quarter, including Louisiana State Employees Retirement System and State of Alaska Department of Revenue. Company insiders that have sold Mesa Laboratories company stock in the last year include David M Kelly, Evan Guillemin, John Bradley Schmieder and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.

MLAB stock was acquired by a variety of institutional investors in the last quarter, including 6 Meridian. View Insider Buying and Selling for Mesa Laboratories.

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MLAB stock can currently be purchased for approximately $265.55.

Mesa Laboratories has a market capitalization of $1.16 billion and generates $103.14 million in revenue each year. The medical instruments supplier earns $7.48 million in net income (profit) each year or $5.37 on an earnings per share basis. Mesa Laboratories employs 366 workers across the globe.View Additional Information About Mesa Laboratories.

The official website for Mesa Laboratories is http://www.mesalabs.com/.

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]